Cover Page»
:: How to recognise Neurocanthocytosis

The first signs of the diseases in the neuroacanthocytosis (NA) group are subtle and easily overlooked. Initial symptoms, which often occur in the person’s mid 20’s, may include grunts or tic noises made unconsciously in the throat, progressing to drooling and problems in controlling the tongue from ejecting food. Involuntary biting of the tongue, lips and/or cheeks may follow.

At the beginning there can be a general, slight physical awkwardness. Things on a shelf are knocked off for no apparent reason. Difficulty with walking and balance can also be early symptoms. Problems controlling trunk, leg and arm movements are often barely noticeable at the beginning, but become increasingly difficult as the disease progresses. Several patients find it difficult to sleep at night and others report fatigue and weakness.

Personality change may also be an early indication. The carefree young adult becomes obsessive-compulsive and uncharacteristically forgetful or just loses confidence or drive. Fainting or epileptic seizures may also occur. Mood changes may happen and a person often becomes isolated, in part out of embarrassment.

There are several reports of the problems beginning after a traumatic event including physical attack, unexpected failure of an exam and birth of a child.

CLINICAL SIGNS

A defining symptom that is not apparent is the spiky red blood cells, or acanthocytes, from which the NA disease group takes its name. These unusual blood cells can be observed with a microscope in some circumstances. Still more difficult to observe are the alterations or mutations in patients’ genes. Each of the NA group diseases has a different genetic characteristic that can be determined only by blood tests.

A person showing some of this pattern of symptoms should see a neurologist. Clinicians and patients can also visit www.naadvocacy.org for links to further scientific reports. Full details are also available on the free blood testing service offered by the Advocacy for Neuroacanthocytosis Patients, aimed at helping determine a definitive diagnosis for NA.



:: Useful NA Resources

  • Neuroacanthocytosis Syndromes II, published December 2007, the book provides a profound insight into recent developments within the field of neuroacanthocytosis syndromes. Edited by Ruth H. Walker, Shinji Saiki and Adrian Danek. Available at amazon.com
  • A Western blot test for the presence of chorein in the membranes of red blood cells can be offered free of charge due to support of the Advocacy for Neuroacanthocytosis Patients'. Download instructions on the blood sampling and specimen shipment as a PDF or get more information on the method at PubMed
  • The entry for chorea acanthocytosis in GeneReviews is the most complete, readily available report on ChAc. Published by the University of Washington with the support of the National Institutes of Health
  • A dedicated Patient & Families Support Group at Yahoo Groups offers patients and families information, advice, support or just an understanding ear
  • Visit PubMed for access to NA research in English from the Medline database.
  • Search Google for the latest on NA
  • Visit the NA page on WeMove, the Movement Disorder Societies charitable and educational associate



:: naadvocacy.org

naadvocacy.org is the website of the The Institute for Neuroacanthocytosis. It is the Advocacy's international centre for supporting patients and promoting clinical and basic research. The website provides access to resources found on the website.

  • Patients' Centre
  • Clinic
  • Library
  • Symposia
  • NA News
  • Research
  • Fundraising


:: Previous Issues
NA News Issue 26

NA News Issue 25

Don't miss the Big Give! Double your donation to NA research this Thursday

NA News Issue 24

NA News Issue 23

NA News Issue 22

NA News Issue 21

NA News Issue 20

NA News Issue 19

NA News Issue 18

NA News Issue 17

NA News Patient Special Issue

NA News Issue 16

NA News Issue 15

NA News Issue 14

NA News Issue 13

NA News Issue 12

NA News Issue 11

:: Join NA News




Eighth Chorea-Acanthocytosis Symposium points the way to future research priorities

The Eighth Chorea-Acanthocytosis Symposium was held May 14 and 15 in Ann Arbor, Michigan, USA. The theme of the meeting was Chorea-Acanthocytosis and Intracellular Transport. A report describing key workshop findings and recommendations for future research priorities is under preparation for publication in a peer-reviewed forum, but a brief overvew of topics covered at the meeting follows here.

The gene involved in ChAc, VPS13A, encoding the chorein protein, is a member of a family of genes involved in transporting a variety of cellular components within cells. The goals of the symposium were to review current research on ChAc, including the functions of genes in this family, and to explore the relationships between ChAc and mechanisms of intracellular transport. The symposium consisted of two parts: a series of presentations on the meeting themes on May 14; and on May 15, a less formal workshop was held, in which many of the participating scientists discussed key issues facing the field of ChAc research. The symposium was held in conjunction with the patient-family meeting.

Participating scientists included investigators presently working on ChAc or VPS13A family genes, and several scientists pursuing basic research on mechanisms of intracellular transport. The Symposium opened an overview of ChAc by Dr. Adrian Danek (Munich, Germany), and a patient-family presentation with Ginger & Alex Irvine and Dr. Ruth Walker (Mt. Sinai School of Medicine; USA). Keynote speakers were Dr. Juan Bonifacino (National Institutes of Health; USA) discussing mechanisms of lysosome motility, and Dr. Dan Klionsky (University of Michigan, USA) discussing autophagy.

Drs. Robert Fuller (University of Michigan, USA), Aaron Nieman (State University of New York-Stony Brook, USA), Benoit Kornmann (ETH Zurich, Switzerland), and Volker Haucke (Berlin, Germany) discussed the function of VPS13A related genes. Drs. Andreas Hermann (Dresden, Germany) and Ody Sibon (Groningen, Netherlands) discussed findings in new model systems of ChAc . Drs. Lois Weisman (University of Michigan, USA), Shigekazu Nagata (Osaka, Japan), and Gil Di Paolo (Denali Therapeutics, USA) discussed important aspects of intracellular transport and relationships with disease mechanisms.

A poster session featured novel results, including recent data on McLeod Syndrome.

The subsequent workshop focused on three topics; our considerable and growing knowledge of the function of the closely related Vps13 gene in the important yeast model system, the development and characterization of novel fruit fly and mouse model systems, and critical needs in ChAc clinical research. Further information key findings and recommendations arising from the meeting will be covered in future issues of NA News.

The meeting was supported financially by the University of Michigan School of Medicine and the Rackham School of Graduate Studies, the Departments of Neurology and Biological Chemistry, philanthropy, and a grant from the Advocacy for Neuroacanthocytosis Patients.




SaveSave
Facebook Twitter LinkedIn